Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition capable of preventing and treating chronic obstructive pulmonary diseases

A chronic obstructive, composition technology, applied in the field of medicine, can solve the problems of not being able to prevent and prevent diseases, and the general long-term effect, so as to achieve the effects of not being easy to catch a cold, alleviating the progress of diseases, and improving physical fitness

Pending Publication Date: 2016-08-17
JINAN KANGZHONG PHARMA TECH DEV
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, it still only focuses on symptomatic treatment of phlegm, deficiency and blood stasis, and fails to fundamentally reveal the cause of chronic obstructive pulmonary disease, and plays a role in prevention and treatment.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0059] Embodiment 1: the granule preparation of medicine of the present invention

[0060] Take the following raw materials by weight:

[0061] Astragalus 1500g, aconite 900g, roasted ephedra 300g, salvia miltiorrhiza 600g, poria 300g, schisandra 300g, bellflower 600g, licorice 300g.

[0062] The above-mentioned crude drug is prepared according to the following method:

[0063] Add water to decoct the crude drug in the weight ratio twice, add 12 times the amount for the first time, decoct for 2 hours, add 10 times the amount for the second time, decoct for 2 hours, combine the medicinal liquid, filter the medicinal liquid, Take the filtrate, concentrate it to a relative density of 1.10-1.15 (60°C), add ethanol to make the alcohol content reach 70%, precipitate, let it stand for 24 hours, absorb the supernatant, recover the ethanol, and obtain the alcohol precipitation liquid; liquid, concentrated, dried, and pulverized to obtain dry paste powder; the obtained dry paste powde...

Embodiment 2

[0064] Embodiment 2: the capsule preparation of medicine of the present invention

[0065] Astragalus 2000g, aconite 1200g, roasted ephedra 450g, salvia miltiorrhiza 400g, poria cocos 500g, schisandra 500g, bellflower 450g, licorice 600g.

[0066] The above-mentioned crude drug is prepared according to the following method:

[0067] Add water to decoct the crude drug in the weight ratio twice, add 12 times the amount for the first time, decoct for 2 hours, add 10 times the amount for the second time, decoct for 2 hours, combine the medicinal liquid, filter the medicinal liquid, Take the filtrate, concentrate it to a relative density of 1.10-1.15 (60°C), add ethanol to make the alcohol content reach 70%, precipitate, let it stand for 24 hours, absorb the supernatant, recover the ethanol, and obtain the alcohol precipitation liquid; liquid, concentrated, dried, and pulverized to obtain dry paste powder; the obtained dry paste powder was thoroughly mixed with an appropriate amou...

Embodiment 3

[0068] Embodiment 3: the tablet preparation of medicine of the present invention

[0069] Take the following raw materials by weight:

[0070] Astragalus 1000g, aconite 1100g, roasted ephedra 600g, salvia miltiorrhiza 900g, poria 400g, schisandra 400g, bellflower 600g, licorice 100g.

[0071] The above-mentioned crude drug is prepared according to the following method:

[0072] Add water to decoct the crude drug in the weight ratio twice, add 10 times the amount of water for the first time, decoct for 1 hour, add 8 times the amount of water for the second time, decoct for 1 hour, combine the medicinal liquid, filter the medicinal liquid, Take the filtrate, concentrate it to a relative density of 1.10-1.15 (60°C), add ethanol to make the alcohol content reach 80%, precipitate, let it stand for 32 hours, absorb the supernatant, recover the ethanol, concentrate, dry, pulverize, and use ethanol The liquid was used as a binder to granulate, dried, and pressed into 2400 tablets. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine composition capable of preventing and treating chronic obstructive pulmonary diseases. The medicine composition comprises 10-20 parts of radix astragali, 6-12 parts of radix aconiti lateralis preparata, 1-6 parts of herba ephedrae preparata, 3-9 parts of radix salviae miltiorrhizae, 1-6 parts of rhizoma pinelliae, 1-6 parts of fructus schisandrae chinensis, 3-9 parts of radix platycodonis and 1-6 parts of radix glycyrrhizae. The medicine composition has the advantages that effects of warming yang, securing the exterior, relieving cough and asthma, eliminating stagnation and dissolving phlegm can be realized by the medicine composition; the chronic obstructive pulmonary diseases can be treated according to etiology of lung diseases such as chronic bronchitis which cause the chronic obstructive pulmonary diseases, symptoms can be relieved, the medicine composition can become effective fast, the constitution of patients can be improved, the problem of aggravation of diseases due to the fact that patients are easy to catch a cold can be solved, and progression of the diseases can be prevented.

Description

technical field [0001] The invention relates to medicines, in particular to a pharmaceutical composition capable of preventing and treating chronic obstructive pulmonary disease, and belongs to the technical field of medicines. technical background [0002] Chronic obstructive pulmonary disease (COPD for short) is a common and frequently-occurring disease characterized by airflow limitation that is not fully reversible and progressively develops, seriously endangering human health, and seriously affecting the quality of life of patients , with high morbidity, high disability and high mortality. my country conducted a survey of 20,245 adults in 7 regions, and the results showed that the prevalence of COPD among people over 40 years old was as high as 8.2%. It is estimated that in 2020, COPD will be the third leading cause of death in the world and the fifth largest economic burden of disease in the world. [0003] Chronic obstructive pulmonary disease is closely related to ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/79A61K36/714A61P11/00
CPCA61K36/076A61K36/17A61K36/346A61K36/481A61K36/484A61K36/537A61K36/57A61K36/714A61K36/79A61K2300/00
Inventor 李诗标张为胜刘圣梅
Owner JINAN KANGZHONG PHARMA TECH DEV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com